Blogs

Lipid-lowering Therapies Should Be Guided by Vascular Imaging Rather Than by Circulating Biomarkers

August 2, 2023

Lipid-lowering Therapies Should Be Guided by Vascular Imaging Rather Than by Circulating Biomarkers

#Heart Health #Reduce Medications

Article

Advantages of tailoring lipid lowering therapy with biomarkers versus imaging.

Dyslipidemia is an important modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD) and lipid lowering an integral component of cardiovascular prevention.

Read full blog here. 

Recommendations

Lipid-lowering Therapies Should Be Guided by Vascular Imaging Rather Than by Circulating Biomarkers

August 2, 2023

Lipid-lowering Therapies Should Be Guided by Vascular Imaging Rather Than by Circulating Biomarkers

#Heart Health #Reduce Medications
Factor XI Inhibitors: The Promise of a Truly Safe Anticoagulant?

October 5, 2023

Factor XI Inhibitors: The Promise of a Truly Safe Anticoagulant?

#Cardiovascular Health #Reduce Medications #Stroke Prevention
Even Exercise by 'Weekend Warriors' Can Cut CV Risk

July 25, 2023

Even Exercise by 'Weekend Warriors' Can Cut CV Risk

#Exercise #Heart Health